About the Academy

A collaborative research training environment

The Ovarian Cancer Academy is a virtual career development and research training platform that consists of Early-Career Investigator/Designated Mentor pairs and two Academy Deans.

OCRP Info Booklet

Academy Highlights

Anti-Tumor Immunity Identified with New Ovarian Cancer Treatment Strategy

Rugang Zhang, Ph.D. finds that a class of drugs known as bromodomain and extraterminal domain (BET) inhibitors could be used to boost anti-tumor immunity and cause T-cells to target the cancer directly while minimizing side effects.

Learn More

Recent Publications

View All
Aug 21, 2019
Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.
Neoplasia. 2019 Aug;21(8):822-836. doi: 10.1016/j.neo.2019.06.005. 
Aug 14, 2019
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants.
Breast Cancer Res Treat. 2019 Aug 14. doi: 10.1007/s10549-019-05403-9.
Aug 14, 2019
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecol Oncol. 2019 Aug 14. pii: S0090-8258(19)31457-X. doi: 10.1016/j.ygyno.2019.08.006.